Sylvette Delee

Sylvette Delee is currently serving as the Oncology Medical Affairs Director at GSK since May 2024. Prior to this role, Sylvette held the position of International Medical Affairs Director at Myriad Genetics from July 2019 to May 2024, focusing on precision medicine and molecular oncology, including launches for Prolaris and MyChoice CDx. Previous experience includes serving as a Medical Advisor in Gynecologic Oncology at Eli Lilly and Company, a Senior Medical Manager at Pfizer and Celgene, and a Medical Manager at Roche. Sylvette's career began as an Emergency/Generalist Physician, complemented by multiple advanced degrees in oncology and medicine from prestigious institutions in Paris. Educational pursuits include an ongoing course in chemotherapy and cancer biology at IGR.